# HIF2α-induced lysyl oxidase safeguards successful pregnancy by remodelling collagens at the feto-maternal interface

**Authors:** Shizu Aikawa, Ryoko Shimizu-Hirota, Akihiko Sakashita, Xueting He, Daiki Hiratsuka, Chihiro Ishizawa, Rei Iida, Yamato Fukui, Takehiro Hiraoka, Mitsunori Matsuo, Norihiko Takeda, Masahito Ikawa, Yutaka Osuga, Yasushi Hirota

PMC · DOI: 10.1038/s41419-026-08485-8 · Cell Death & Disease · 2026-03-09

## TL;DR

The study shows how hypoxia in the uterus helps pregnancy by triggering HIF2α and lysyl oxidase to reshape the tissue where the embryo implants.

## Contribution

The study identifies HIF2α and lysyl oxidase as key players in hypoxia-driven extracellular matrix remodeling during early pregnancy.

## Key findings

- HIF2α induces lysyl oxidase to stabilize collagen fibrils at the feto-maternal interface.
- Disruption of HIF2α or lysyl oxidase in the uterus leads to infertility due to impaired trophoblast invasion.
- Extracellular matrix remodeling in the decidua is critical for successful embryo implantation and placental formation.

## Abstract

During the initial stage of gestation, precise constructions of the microenvironment at the feto-maternal interface are critical for successful embryonic development to term. It consists of the fetal placenta and the maternal decidua, contributing to favorable pregnancy outcomes and long-term health in both mother and child. Remarkably, although our previous work demonstrated that physiological uterine hypoxia promotes blastocyst implantation into the decidua basalis and onset of trophoblastic invasion via the hypoxia-inducible factor (Hif) signaling pathway, it remains unclear which key regulatory cascades are triggered underlying. Here, we harnessed recent advances of the spatial transcriptomic technology in combination with genetic mouse models to gain a more comprehensive understanding of physiological uterine hypoxia. We revealed that hypoxia-induced remodeling of the extracellular matrices (ECMs) allows the blastocyst-derived trophoblastic cells to invade into the uterine stroma upon implantation. Mechanistically, Hif2α drives the expression of lysyl oxidase (Lox) that crosslinks collagen I fibrils and their stabilization in the vicinity of the attached embryos. Uterine-specific knockout (uKO) of Hif2α and Lox compromised the process of embryo invasion, leading to female infertility. Collectively, our findings provide mechanistic insight into how hypoxia governs early embryonic invasion and contributes to successful pregnancy.

Hypoxia in the primary decidual zone induces Hif2α, which regulates lysyl oxidase (Lox) expression to remodel the extracellular matrix at the feto–maternal interface.Genetic disruption of Hif2α or Lox in the uterus impairs trophoblast invasion and compromises fertility, highlighting a critical hypoxia-driven signaling axis.Remodeling of the maternal decidual ECM network directly influences embryonic invasive capacity and subsequent placental formation, underscoring the importance of maternal tissue architecture in pregnancy outcomes.

Hypoxia in the primary decidual zone induces Hif2α, which regulates lysyl oxidase (Lox) expression to remodel the extracellular matrix at the feto–maternal interface.

Genetic disruption of Hif2α or Lox in the uterus impairs trophoblast invasion and compromises fertility, highlighting a critical hypoxia-driven signaling axis.

Remodeling of the maternal decidual ECM network directly influences embryonic invasive capacity and subsequent placental formation, underscoring the importance of maternal tissue architecture in pregnancy outcomes.

## Linked entities

- **Genes:** EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034], LOX (lysyl oxidase) [NCBI Gene 4015]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, Lox (lysyl oxidase) [NCBI Gene 16948] {aka TSC-160, rrg}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, Nsdhl (NAD(P) dependent steroid dehydrogenase-like) [NCBI Gene 18194] {aka Bpa, H105E3, Str, XAP104}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Pgr (progesterone receptor) [NCBI Gene 18667] {aka 9930019P03Rik, NR3C3, PR, PR-A, PR-B}, Epas1 (endothelial PAS domain protein 1) [NCBI Gene 13819] {aka HIF-2alpha, HIF2A, HLF, HRF, MOP2, bHLHe73}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, Fbn1 (fibrillin 1) [NCBI Gene 14118] {aka B430209H23, Fib-1, Tsk}, KRT8 (keratin 8) [NCBI Gene 3856] {aka CARD2, CK-8, CK8, CYK8, K2C8, K8}, Lif (leukemia inhibitory factor) [NCBI Gene 16878], YY1AP1 (YY1 associated protein 1) [NCBI Gene 55249] {aka GRNG, HCCA1, HCCA2, YY1AP}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, Tead1 (TEA domain family member 1) [NCBI Gene 21676] {aka 2610024B07Rik, B230114H05Rik, Gtrgeo5, TEAD-1, TEF-1, Tcf13}, Krt8 (keratin 8) [NCBI Gene 16691] {aka Card2, EndoA, K8, Krt-2.8, Krt2-8, TROMA-1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Foxa2 (forkhead box A2) [NCBI Gene 15376] {aka HNF3-beta, HNF3beta, Hnf-3b, Hnf3b, Tcf-3b, Tcf3b}
- **Diseases:** Metabolic Disorders (MESH:D008659), Hypoxia (MESH:D000860), pregnancy defects (MESH:D011254), miscarriage (MESH:D000022), bleeding (MESH:D006470), Hypoxic (MESH:D002534), cancer (MESH:D009369), infertility (MESH:D007246), preeclampsia (MESH:D011225), intrauterine growth restriction (MESH:D005317), female infertility (MESH:D007247)
- **Chemicals:** glutaraldehyde (MESH:D005976), formalin (MESH:D005557), 4',6-diamidino-2-phenylindole (MESH:C007293), agarose (MESH:D012685), paraformaldehyde (MESH:C003043), FITC (MESH:D016650), Hypoxyprobe-1 (MESH:C033815), Alexa Fluor 488 (MESH:C000711379), H&amp;E (MESH:D006371), Alexa 555 (-), paraffin (MESH:D010232), oxygen (MESH:D010100), Alexa Fluor 647 (MESH:C569686), phosphate (MESH:D010710)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** R210H
- **Cell lines:** M — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_M133), SDZ — Homo sapiens (Human), Prostate carcinoma, Telomerase immortalized cell line (CVCL_UZ14), AM — Helicoverpa zea (Corn earworm moth), Spontaneously immortalized cell line (CVCL_Z401)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12972092/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12972092/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12972092/full.md

---
Source: https://tomesphere.com/paper/PMC12972092